MAISNAR, Vladimír, Roman HÁJEK, Vlastimil ŠČUDLA, Evžen GREGORA, Tomáš BÜCHLER, Miloš TICHÝ, Pavol KOTOUČEK, Adriana KAFKOVÁ, Lubica FORRAIOVÁ, Jiří MINAŘÍK, Jakub RADOCHA, V. BLÁHA and Jaroslav MALÝ. High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma. Bone Marrow Transplantation. London: Nature Publishing Group, 2008, vol. 41, No 1, p. 51-54. ISSN 0268-3369.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma.
Name in Czech Autologní transplantace kmenových buněk po vysokodávkované chemoterapii mění prognózu IgD mnohočetného myelomu
Authors MAISNAR, Vladimír, Roman HÁJEK, Vlastimil ŠČUDLA, Evžen GREGORA, Tomáš BÜCHLER, Miloš TICHÝ, Pavol KOTOUČEK, Adriana KAFKOVÁ, Lubica FORRAIOVÁ, Jiří MINAŘÍK, Jakub RADOCHA, V. BLÁHA and Jaroslav MALÝ.
Edition Bone Marrow Transplantation, London, Nature Publishing Group, 2008, 0268-3369.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.400
Organization unit Faculty of Medicine
UT WoS 000252388700009
Keywords (in Czech) mnohočetný myelom; autologní transplantace; chemoterapie
Keywords in English multiple myeloma;stem cell; autologous translantation; high-dose chemotherapy
Tags autologous translantation, high-dose chemotherapy, multiple myeloma, stem cell
Tags International impact, Reviewed
Changed by Changed by: Ing. Gabriela Petrovičová, učo 239322. Changed: 22/6/2009 10:55.
Abstract
Immunoglobulin D (IgD) multiple myeloma (MM) is a rare plasma cell disorder constituting less than 2% of all MM cases. Survival of patients with IgD MM is generally shorter than that of patients with other types of monoclonal (M-) protein. We have retrospectively analyzed patients with IgD MM participating in clinical trials of the Czech Myeloma Group.
Abstract (in Czech)
Autologní transplantace kmenových buněk po vysokodávkované chemoterapii mění prognózu IgD mnohočetného myelomu.
PrintDisplayed: 18/7/2024 12:21